Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

The US Department of State has announced a life-saving development to bring US-based Gilead Sciences’ breakthrough drug ...

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

Talk about bad blood. Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

Lenacapavir is a breakthrough long-acting HIV prevention drug, which Motsoaledi has labelled a turning point in the country’s ...

KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...

Nursing home patients with HIV tend to be younger. They also typically have more comorbidities than the average patient, and ...

A growing trend of injecting the blood of other drug users to get a quick high, a practice called “bluetoothing”, has been ...

Aaron Motsoaledi warned, however, that initial distribution of the drug would be limited to nearly half a million people.